Peter S. Hammerman
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Fibroblast Growth Factor Research 13
- RNA modifications and cancer 12
- Epigenetics and DNA Methylation 8
-
- Lung Cancer Treatments and Mutations 23
- Co-authors
- Craig B. Thompson (9 shared papers)Casey Fox (8 shared papers)Kwok‐Kin Wong (21 shared papers)Christine M. Fillmore (3 shared papers)Carla F. Kim (3 shared papers)Ryan M. Cinalli (3 shared papers)David R. Plas (2 shared papers)Jeffrey C. Rathmell (2 shared papers)
- Journals
- Cancer Research (15 papers)Journal of Clinical Oncology (7 papers)Clinical Cancer Research (6 papers)Blood (5 papers)Molecular Cancer Therapeutics (5 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Peter S. Hammerman
83 papers receiving 8.1k citations
Peter S. Hammerman's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 1.8k
- Oncology 2.5k
- Immunology 1.4k
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 3.8k
Countries citing papers authored by Peter S. Hammerman
This map shows the geographic impact of Peter S. Hammerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Hammerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Hammerman more than expected).
Fields of papers citing papers by Peter S. Hammerman
This network shows the impact of papers produced by Peter S. Hammerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Hammerman. The network helps show where Peter S. Hammerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter S. Hammerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Non-small-cell lung cancers: a heterogeneous set of diseases Hit paper breakdown → | 2014 | 1415 |
| 2 | Fuel feeds function: energy metabolism and the T-cell response Hit paper breakdown → | 2005 | 681 |
| 3 | MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression Hit paper breakdown → | 2016 | 499 |
| 4 | 2003 | 480 | |
| 5 | Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma Hit paper breakdown → | 2017 | 370 |
| 6 | 2011 | 296 | |
| 7 | 2003 | 272 | |
| 8 | 2016 | 239 | |
| 9 | 2016 | 235 | |
| 10 | 2015 | 212 | |
| 11 | 2015 | 195 | |
| 12 | 2005 | 172 | |
| 13 | 2010 | 169 | |
| 14 | 2007 | 152 | |
| 15 | 2005 | 151 | |
| 16 | 2004 | 143 | |
| 17 | 2013 | 135 | |
| 18 | 2015 | 121 | |
| 19 | 2009 | 120 | |
| 20 | 2016 | 117 |
About Peter S. Hammerman
Peter S. Hammerman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 87 papers that have together received 8.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Fibroblast Growth Factor Research (13 papers), Cancer Genomics and Diagnostics (12 papers), RNA modifications and cancer (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Epigenetics and DNA Methylation (8 papers), Lung Cancer Research Studies (6 papers) and Head and Neck Cancer Studies (6 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (2.5k citations), Immunology (1.4k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Molecular Biology (3.8k citations). Peter S. Hammerman has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Craig B. Thompson, Casey Fox, Kwok‐Kin Wong, Christine M. Fillmore, Carla F. Kim, Ryan M. Cinalli, David R. Plas, Jeffrey C. Rathmell, Yvonne Y. Li and Pasi A. Jänne. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Blood and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.